Inflammatory bowel disease biologic blunts immune response to COVID-19

WHO: Global coronavirus deaths rise for 1st time in 6 weeks
22 March 2021
Study identifies concerning delays in tuberculosis diagnoses in the US
22 March 2021

Inflammatory bowel disease biologic blunts immune response to COVID-19

Careful monitoring of patients treated with infliximab needed after COVID jab

Comments are closed.